Clinical Trial Update: Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of Vitamin K2 (MK7) supplementation on cardiovascular and bone health in patients with end-stage renal disease und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Disease
• Cardiovascular Disease
• End-stage Renal Disease

Drugs mentioned

• Vitamin K2 (MK7) (menaquinone-7)

Snippet

Sponsor: Zealand University Hospital | Conditions: Vitamin K Supplementation, Endstage Renal Disease | Phase 4 | Status: COMPLETED